Anticancer Properties of Novel Rhenium Pentylcarbanato Compounds against MDA-MB-468(HTB-132) Triple Node Negative Human Breast Cancer Cell Lines

AIM: To study the efficacy of novel rhenium compounds to treat triple node negative breast cancer. PLACE AND DURATION: Six (6) novel rhenium pentycarbanato compounds (PC1-6) were synthesized and triple node negative breast cancer cell lines HTB-132 and Balb/c mouse kidney cell lines were treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Parson, Carl, Smith, Valerie, Krauss, Christopher, Banerjee, Hirendra N., Reilly, Christopher, Krause, Jeanette A., Wachira, James M., Giri, Dipak, Winstead, Angela, Mandal, Santosh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235525/
https://www.ncbi.nlm.nih.gov/pubmed/25419517
http://dx.doi.org/10.9734/BJPR/2014/4697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235525/
https://www.ncbi.nlm.nih.gov/pubmed/25419517
http://dx.doi.org/10.9734/BJPR/2014/4697

Ejemplares similares